Echocardiographic findings in long-term, long-hour hemodialysis patients

被引:0
作者
Covic, A
Goldsmith, DJA
Georgescu, G
Venning, MC
Ackrill, P
机构
[1] WITHINGTON HOSP,WITHINGTON HOSP ARTIFICIAL KIDNEY UNIT,MANCHESTER,LANCS,ENGLAND
[2] UNIV IASI,PARHON HOSP,IASI,ROMANIA
[3] UNIV IASI,ST SPIRIDON HOSP,IASI,ROMANIA
关键词
ambulatory; blood pressure; hemodialysis; echocardiography; left ventricular hypertrophy;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
This article describes the echocardiographic structural and functional findings in a cohort of 30 patients on ten or more years of uninterrupted long-hour (24 hours per week dialysis schedule) hemodialysis (mean duration 187.7 months, range 120 to 299 months). Cardiac structural analysis was remarkable for the prevalence of LVH (76%), very rarely asymmetric (3%). Hemoglobin and (log) plasma renin activity were determinants of the LV wall thickness ratio (r = -0.57 and 0.54, p = 0.003 and 0.044 respectively). Markers of systolic contractile;function were frequently normal (100% MVCFS; 85% FSI). Diastolic ventricular compliance was abnormal in 59% of patients, Blood pressure history appeared important in determining LVH, but office/ABPM measures of BP were not. Patients after parathyroidectomy (PTx) had a smaller LVPWTN (8.68 mm/m(2) without PTx cf 7.01 mm/m(2) after PTx, p = 0.036). Left ventricular cavity size was rarely enlarged (10%), with hemoglobin (r = -0.47, p = 0.012) and PTH (r = -0.65, p <0.001) the major determinants of EDDN. Left atrial diameter was increased in 77% of patients. Cardiac valvular calcification was seen in 50% of patients. Our findings show that despite good BP control without recourse to antihypertensive drugs, LVH with good LV systolic function is very common in these long-survivors.
引用
收藏
页码:104 / 110
页数:7
相关论文
共 28 条
[1]  
BOMMER J, 1992, OXFORD TXB CLIN NEPH, V2
[2]   CONTROL OF HYPERTENSION AND PROLONGED SURVIVAL ON MAINTENANCE HEMODIALYSIS [J].
CHARRA, B ;
CALEMARD, E ;
CUCHE, M ;
LAURENT, G .
NEPHRON, 1983, 33 (02) :96-99
[3]  
DEVEREUX RB, 1995, J HYPERTENS, V12, P117
[4]  
FEIGENBAUM H, 1993, ECHOCARDIOGRAPHY
[5]   PARATHYROID-HORMONE AND MYOCARDIAL PERFORMANCE IN DIALYSIS PATIENTS [J].
FELLNER, SK ;
LANG, RM ;
NEUMANN, A ;
BUSHINSKY, DA ;
BOROW, KM .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1991, 18 (03) :320-325
[6]  
FRIEDMAN EA, 1992, DISEASES KIDNEY, V3, P3069
[7]   ASSESSING THE ADEQUACY OF DIALYSIS [J].
HAKIM, RM ;
HARRINGTON, JT ;
LEVEY, AS ;
KASSIRER, JP ;
MADIAS, NE ;
BERNARD, DB ;
PERRONE, RD ;
MEYER, K ;
CARLSON, J ;
MADAIO, MP .
KIDNEY INTERNATIONAL, 1990, 37 (02) :822-832
[8]  
HARNETT JD, 1993, P AM SOC NEPHR BOST
[9]   PROCEEDINGS FROM THE MORBIDITY, MORTALITY AND PRESCRIPTION OF DIALYSIS SYMPOSIUM, DALLAS, TX, SEPTEMBER 15 TO 17, 1989 - INTRODUCTION AND SUMMARY [J].
HULL, AR ;
PARKER, TF .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1990, 15 (05) :375-383
[10]   ANALYSIS OF LEFT-VENTRICULAR CHANGES ASSOCIATED WITH CHRONIC-HEMODIALYSIS - A NONINVASIVE FOLLOW-UP-STUDY [J].
HUTING, J ;
KRAMER, W ;
SCHUTTERLE, G ;
WIZEMANN, V .
NEPHRON, 1988, 49 (04) :284-290